Sabzevari Helen

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(3%)38%0%0%
Sale Success Rate1 of 20 of 21 of 20 of 20 of 2
Drugs » Biotechnology

President and CEO, Director:

Holdings: 402.14K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--